In this study, we report that serum and synovial RANKL levels, used as surrogate makers of local and systemic bone destruction, are higher in ACPA-positive than in ACPA-negative newly diagnosed untreated RA patients. Here, TNFSF11 is linked to rheumatoid arthritis.